Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shubham Shrivastava

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Virology|July 5, 2025
Performance evaluation of micro-foci reduction neutralization test for the detection of neutralizing antibodies in human samples against dengue viruses circulating in IndiaShweta Chelluboina, Sneha Borkar, Akhilesh Chandra Mishra, et al.
Plos One|May 3, 2013
Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasmCintia Bittar, Shubham Shrivastava, Joydip Bhanja Chowdhury, et al.
Journal of Virology|June 8, 2012
Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signalingShubham Shrivastava, Joydip Bhanja Chowdhury, Robert Steele, et al.
The American Journal of Tropical Medicine and Hygiene|September 11, 2025
Maternal Antibody Kinetics and Infant Susceptibility to Dengue Infection in IndiaShubham Shrivastava, Amita Kasana, Ruta Kulkarni, et al.
Journal of Virology|May 3, 2014
Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expressionAnupam Mukherjee, Shubham Shrivastava, Joydip Bhanja Chowdhury, et al.
Plos One|August 29, 2025
Evaluation of methods for the measurement of antibody-dependent enhancement of dengue virus infection using different FcγRIIa expressing cell linesShweta Chelluboina, Darshan Kshirsagar, Gauri Panzade, et al.
Journal of Virology|October 7, 2011
ISG56 and IFITM1 proteins inhibit hepatitis C virus replicationAmit Raychoudhuri, Shubham Shrivastava, Robert Steele, et al.
Vaccine|September 15, 2009
Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approachShubham Shrivastava, Kavita S Lole, Anuradha S Tripathy, et al.
Scientific Reports|January 16, 2015
Identification of molecular signature of head and neck cancer stem-like cellsShubham Shrivastava, Robert Steele, Melanie Sowadski, et al.
Immunity, Inflammation and Disease|January 16, 2021
Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severityArchana Kulkarni-Munje, Sonali Palkar, Shubham Shrivastava, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Virology|July 5, 2025
Performance evaluation of micro-foci reduction neutralization test for the detection of neutralizing antibodies in human samples against dengue viruses circulating in IndiaShweta Chelluboina, Sneha Borkar, Akhilesh Chandra Mishra, et al.
Plos One|May 3, 2013
Hepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasmCintia Bittar, Shubham Shrivastava, Joydip Bhanja Chowdhury, et al.
Journal of Virology|June 8, 2012
Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signalingShubham Shrivastava, Joydip Bhanja Chowdhury, Robert Steele, et al.
The American Journal of Tropical Medicine and Hygiene|September 11, 2025
Maternal Antibody Kinetics and Infant Susceptibility to Dengue Infection in IndiaShubham Shrivastava, Amita Kasana, Ruta Kulkarni, et al.
Journal of Virology|May 3, 2014
Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expressionAnupam Mukherjee, Shubham Shrivastava, Joydip Bhanja Chowdhury, et al.
Plos One|August 29, 2025
Evaluation of methods for the measurement of antibody-dependent enhancement of dengue virus infection using different FcγRIIa expressing cell linesShweta Chelluboina, Darshan Kshirsagar, Gauri Panzade, et al.
Journal of Virology|October 7, 2011
ISG56 and IFITM1 proteins inhibit hepatitis C virus replicationAmit Raychoudhuri, Shubham Shrivastava, Robert Steele, et al.
Vaccine|September 15, 2009
Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approachShubham Shrivastava, Kavita S Lole, Anuradha S Tripathy, et al.
Scientific Reports|January 16, 2015
Identification of molecular signature of head and neck cancer stem-like cellsShubham Shrivastava, Robert Steele, Melanie Sowadski, et al.
Immunity, Inflammation and Disease|January 16, 2021
Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severityArchana Kulkarni-Munje, Sonali Palkar, Shubham Shrivastava, et al.
Pageof 5